Showing results (131-140 of 2,599) with videos related to
Sort By:
Pageof 260
Psychiatry Research|October 1, 1982
Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patientsS C Schulz, D P van Kammen, D Pickar, et al.Psychopharmacology|January 1, 1981
Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reductionD Pickar, R M Cohen, D C Jimerson, et al.The Journal of Clinical Psychiatry|September 1, 1994
Predictors of clozapine response in schizophreniaD Pickar, R R Owen, R E Litman, et al.Psychosomatic Medicine|September 1, 1984
Plasma cortisol and beta-endorphin immunoreactivity in human obesityM R Cohen, D Pickar, R M Cohen, et al.The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1996
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapineR E Litman, T P Su, W Z Potter, et al.The American Journal of Psychiatry|October 10, 1998
Dopamine D2 receptor density and personal detachment in healthy subjectsA Breier, L Kestler, C Adler, et al.Neuropeptides|July 1, 1985
Hormonal effects of high dose naloxone in humansM R Cohen, R M Cohen, D Pickar, et al.Archives of General Psychiatry|May 1, 1992
Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazineD Pickar, R R Owen, R E Litman, et al.JAMA|June 2, 1993
Neuropsychiatric effects of anabolic steroids in male normal volunteersT P Su, M Pagliaro, P J Schmidt, et al.The American Journal of Psychiatry|October 1, 1982
High plasma norepinephrine levels in patients with major affective disorderC R Lake, D Pickar, M G Ziegler, et al.Pageof 260